A new era in posterior segment ocular drug delivery: Translation of systemic, cell-targeted, dendrimer-based therapies
Vision impairment and loss due to posterior segment ocular disorders, including age-related
macular degeneration and diabetic retinopathy, are a rapidly growing cause of disability …
macular degeneration and diabetic retinopathy, are a rapidly growing cause of disability …
[HTML][HTML] Advances in PSMA theranostics
TM Jeitner, JW Babich, JM Kelly - Translational Oncology, 2022 - Elsevier
The validation of prostate specific membrane antigen (PSMA) as a molecular target in
metastatic castration-resistant prostate cancer has stimulated the development of multiple …
metastatic castration-resistant prostate cancer has stimulated the development of multiple …
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
M Mistretta, A Farini, Y Torrente, C Villa - Brain, 2023 - academic.oup.com
Neurodegenerative diseases are a major global health burden particularly with the
increasing ageing population. Hereditary predisposition and environmental risk factors …
increasing ageing population. Hereditary predisposition and environmental risk factors …
Polymeric dendrimers as nanocarrier vectors for neurotheranostics
Dendrimers are polymers with well‐defined 3D branched structures that are vastly utilized in
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …
Inhibition of glutamate-carboxypeptidase-II in dorsolateral prefrontal cortex: potential therapeutic target for neuroinflammatory cognitive disorders
Glutamate carboxypeptidase-II (GCPII) expression in brain is increased by inflammation, eg
by COVID19 infection, where it reduces NAAG stimulation of metabotropic glutamate …
by COVID19 infection, where it reduces NAAG stimulation of metabotropic glutamate …
Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders
AFT Arnsten, Y Ishizawa, Z Xie - Molecular Psychiatry, 2023 - nature.com
Neuroinflammatory disorders preferentially impair the higher cognitive and executive
functions of the prefrontal cortex (PFC). This includes such challenging disorders as …
functions of the prefrontal cortex (PFC). This includes such challenging disorders as …
Dendrimers in neurodegenerative diseases
MD Pérez-Carrión, I Posadas - Processes, 2023 - mdpi.com
Neurodegenerative diseases (NDs), such as Parkinson's Disease (PD), Alzheimer's Disease
(AD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS), are characterized by …
(AD), Multiple Sclerosis (MS) and amyotrophic lateral sclerosis (ALS), are characterized by …
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
M Beygi, F Oroojalian, S Azizi‐Arani… - Advanced Functional …, 2024 - Wiley Online Library
The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed
with tight junctions and adherent junctions that regulates the transport of various materials …
with tight junctions and adherent junctions that regulates the transport of various materials …
Scientific rationale for the treatment of cognitive deficits from long COVID
A Fesharaki Zadeh, AFT Arnsten, M Wang - Neurology International, 2023 - mdpi.com
Sustained cognitive deficits are a common and debilitating feature of “long COVID”, but
currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral …
currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral …
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model
Abstract Background Cognitive decline in Alzheimer's disease (AD) is associated with
hyperphosphorylated tau (pTau) propagation between neurons along synaptically …
hyperphosphorylated tau (pTau) propagation between neurons along synaptically …